Table 4.

Hemoglobin A1c and Other Glycemic Indices After One Year of TKI Therapy

	Dasatinib	Imatinib	Difference	* P-value
Number	13	22
Hemoglobin A1c (%)	−0.74 ± 1.06	0.06 ± 1.25	−0.80	0.05
Total daily insulin (Units)	−18.8 ± 21.9	−0.6 ± 15.3	−18.2	0.16
Other antihyperglycemic medications	−0.1 ± 0.3	−0.1 ± 0.6	0.0	0.93
Weight (kg)	−3.0 ± 7.6	2.8 ± 10.1	5.9	0.06
Body mass (%)	−3.1 ± 3.06	3.2 ± 9.6	6.3	0.04

^*P-values obtained using a 2-tailed two-sample t-test assuming unequal variances for continuous variables, or Fisher’s exact test for categorical variables